Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05355389Not ApplicableRecruiting

Cognitive-motor Telerehabilitation in MS

Role: collaborator

NCT07288541Not ApplicableNot Yet Recruiting

Promoting Positive Emotions in Adolescents Using Positive Events Training: An Indicated Approach

Role: collaborator

NCT07285733Completed

Multimodal Neuromonitoring at the ICU

Role: collaborator

NCT06973837Recruiting

Studying the Neurobiological Mechanisms of Non-specific Chronic Low Back Pain and Chronic Insomnia: a Four-group Cross-sectional Study

Role: collaborator

NCT07263984Not ApplicableRecruiting

Added Value of Three-dimensional Transvaginal Ultrasound (3D TVUS) and Gel Infusion Sonography (3D GIS) Compared With Magnetic Resonance Imaging (MRI) in the Diagnosis of Patients With Suspicion of a Uterine Septum.

Role: collaborator

NCT07261891Not ApplicableRecruiting

Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders

Role: collaborator

All 6 trials loaded